Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max O'Donnell

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Lancet. Infectious Diseases|March 25, 2024
The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis-lessons from the South African experienceKogieleum Naidoo, Rubeshan Perumal, Helen Cox, et al.
Tropical Medicine & International Health : TM & IH|September 14, 2010
Extensively drug-resistant tuberculosis (XDR-TB) among health care workers in South AfricaJulie Jarand, Karen Shean, Max O'Donnell, et al.
The Lancet. Microbe|January 12, 2024
Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysisCamus Nimmo, Neda Bionghi, Matthew J Cummings, et al.
The Lancet. Microbe|August 18, 2020
Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysisCamus Nimmo, James Millard, Lucy van Dorp, et al.
The European Respiratory Journal|November 9, 2023
Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: a systematic review and meta-analysisRubeshan Perumal, Neda Bionghi, Camus Nimmo, et al.
The European Respiratory Journal|February 16, 2020
Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patientsCamus Nimmo, James Millard, Kayleen Brien, et al.
Annals of the American Thoracic Society|September 26, 2019
Lung Function and Respiratory Symptoms after Tuberculosis in an American Indian Population. The Strong Heart StudyMartha Powers, Tiffany R Sanchez, Thomas K Welty, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2024
Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infectionKarl Reis, Allison Wolf, Rubeshan Perumal, et al.
BMC Infectious Diseases|May 1, 2026
Socio-ecological vulnerability subgroups predict adherence and treatment outcomes in multidrug-resistant tuberculosis and HIV: a latent class analysisKevin J Guzman, Allison Wolf, Rubeshan Perumal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2026
Characterizing the dual burden of stigma in people with multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in South Africa: A mixed methods, prospective cohort studyKarl Reis, Xuan Lu, Boitumelo Seepamore, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Lancet. Infectious Diseases|March 25, 2024
The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis-lessons from the South African experienceKogieleum Naidoo, Rubeshan Perumal, Helen Cox, et al.
Tropical Medicine & International Health : TM & IH|September 14, 2010
Extensively drug-resistant tuberculosis (XDR-TB) among health care workers in South AfricaJulie Jarand, Karen Shean, Max O'Donnell, et al.
The Lancet. Microbe|January 12, 2024
Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysisCamus Nimmo, Neda Bionghi, Matthew J Cummings, et al.
The Lancet. Microbe|August 18, 2020
Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysisCamus Nimmo, James Millard, Lucy van Dorp, et al.
The European Respiratory Journal|November 9, 2023
Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: a systematic review and meta-analysisRubeshan Perumal, Neda Bionghi, Camus Nimmo, et al.
The European Respiratory Journal|February 16, 2020
Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patientsCamus Nimmo, James Millard, Kayleen Brien, et al.
Annals of the American Thoracic Society|September 26, 2019
Lung Function and Respiratory Symptoms after Tuberculosis in an American Indian Population. The Strong Heart StudyMartha Powers, Tiffany R Sanchez, Thomas K Welty, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2024
Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infectionKarl Reis, Allison Wolf, Rubeshan Perumal, et al.
BMC Infectious Diseases|May 1, 2026
Socio-ecological vulnerability subgroups predict adherence and treatment outcomes in multidrug-resistant tuberculosis and HIV: a latent class analysisKevin J Guzman, Allison Wolf, Rubeshan Perumal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2026
Characterizing the dual burden of stigma in people with multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in South Africa: A mixed methods, prospective cohort studyKarl Reis, Xuan Lu, Boitumelo Seepamore, et al.
Pageof 4